Anlon Healthcare Limited Stock Price

NSEI:AHCL Community·₹8.3b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Author Program NEW Create Narrative

AHCL Share Price Performance

₹15.63

6.46 (70.39%)

₹15.63

6.46 (70.39%)

₹15.63

Wed, 29 Jul 26

Share Pricen/a

AHCL Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Excellent balance sheet with questionable track record.

2 Risks

2 Rewards

View Full Analysis

Anlon Healthcare Limited Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 0.54
: 38.88%
: 16.58%
: 17.1%

View Full Analysis

About AHCL

Founded: 2013
Employees: n/a
CEO: Punitkumar Rasadia
WebsiteView website: www.anlon.in

Anlon Healthcare Limited manufactures and sells advance pharmaceutical intermediates in India and internationally. The company offers active pharmaceutical ingredients (API); nutraceutical API products; personal care ingredients; and veterinary API products. Its products are used in anti-inflammatory (NSAID), analgesic, antipyretic, antihistamine, antidepressant, antipsychotic, anticoagulant, antihypertensive, nutrition, anti-arrhythmic, anti-hyper parathyroid, antiplatelet, ant diabetic, gastroesophageal reflux disease (GERD), and anti-rheumatic therapeutics areas. The company was incorporated in 2013 and is based in Rajkot, India.